Current Advances in Pancreatic Cancer Research and Treatment
September 10, 2014
8:45 am - 3:40 pm
NEW LOCATION: Natcher Building 45, Balcony C
Registration is free but required
Sponsored By: Pancreatic Cancer Interest Group and GI Malignancy Faculty
Pancreatic cancer remains one of the most lethal malignancies and is expected to be the second leading cause of death due to cancer in 2020. Recent surge in the basic and clinical research has identified promising targets that may be useful in improving survival in patients with pancreatic cancer. This symposium addresses recent advances in the development, progression and treatment of pancreatic cancer, and should provide an exciting forum to discuss the challenges in improving diagnosis, prevention and disease outcome.
- Molecular Taxonomy of Pancreatic Neoplasia
- Tumor Biology Driven Treatment
- Inflammatory Mediators
- Neoadjuvant Approaches
- Genetics and Epigenetics
- miRNA as therapeutic targets
S. Perwez Hussain, Tim Greten, Laufey Amundadottir, Thomas Ried, Xin Wang, Raffit Hassan
The two best selected posters will get a Travel Award of $500.